Letter: complex interplay between obesity and Clostridium difficile infection

被引：1
|
作者：
Kapur, A. [1 ]
Nagaraja, V. [2 ,3 ]
机构：
[1] Wollongong Hosp, Dept Gastroenterol, Wollongong, NSW, Australia
[2] Prince Wales Hosp, Randwick, NSW, Australia
[3] Community Hlth Serv, Randwick, NSW, Australia
来源：
ALIMENTARY PHARMACOLOGY & THERAPEUTICS | 2017年 / 46卷 / 06期
关键词：
GUT MICROBIOTA; RISK-FACTOR; ANTIBIOTICS; ASSOCIATION; DISEASE;
D O I：
10.1111/apt.14229
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
引用
收藏
页码：639 / 641
页数：5
相关论文
共 50 条
  • [41] The management of Clostridium difficile infection
    Williams, O. Martin
    Spencer, Robert C.
    BRITISH MEDICAL BULLETIN, 2009, 91 (01) : 87 - 110
  • [42] Probiotics in Clostridium difficile Infection
    Na, Xi
    Kelly, Ciaran
    JOURNAL OF CLINICAL GASTROENTEROLOGY, 2011, 45 : S154 - S158
  • [43] Clostridium difficile infection:: appendix
    Wilcox, MH
    JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY, 1998, 41 : 71 - 72
  • [44] Update on Clostridium difficile infection
    O'Donoghue, Caoilfhionn
    Kyne, Lorraine
    CURRENT OPINION IN GASTROENTEROLOGY, 2011, 27 (01) : 38 - 47
  • [45] Epidemiology of Clostridium Difficile Infection
    Stausberg, Juergen
    DEUTSCHES ARZTEBLATT INTERNATIONAL, 2015, 112 (19): : 345 - 345
  • [46] Treating Clostridium difficile infection
    Shafran, Daniel M.
    Shafran, Stephen D.
    CANADIAN MEDICAL ASSOCIATION JOURNAL, 2014, 186 (07) : 531 - 531
  • [47] Clostridium difficile infection and surgery
    Gourevitch, D.
    Hawkey, P.
    BRITISH JOURNAL OF SURGERY, 2009, 96 (01) : 3 - 4
  • [48] Treatment of Clostridium difficile infection
    Wilcox, MH
    JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY, 1998, 41 : 41 - 46
  • [49] Clostridium difficile Infection Preface
    Wilcox, Mark H.
    INFECTIOUS DISEASE CLINICS OF NORTH AMERICA, 2015, 29 (01) : XIII - XIV
  • [50] Clostridium difficile infection in Australia
    Foster, Niki F.
    Riley, Thomas V.
    MICROBIOLOGY AUSTRALIA, 2014, 35 (01) : 26 - 28
12345